Get started
Author

Taishi Hashiguchi

Observed name: TAISHI HASHIGUCHI
ORCID: 0009-0002-3377-7628
Observed ORCID: 0009-0002-3377-7628
OpenAlex ID: A5083646597
Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis
2016 · Eric Lefebvre, Graeme Moyle, et al. · PLoS ONE · 331
PDF
Faulty Initiation of Proteoglycan Synthesis Causes Cardiac and Joint Defects
2011 · Sevjidmaa Baasanjav, Lihadh Al-Gazali, et al. · The American Journal of Human Genetics · 134
PDF
Involvement of Highly Sulfated Chondroitin Sulfate in the Metastasis of the Lewis Lung Carcinoma Cells
2008 · Fuchuan Li, Gerdy B. ten Dam, et al. · Journal of Biological Chemistry · 102
PDF
Insulin resistance dysregulates CYP7B1 leading to oxysterol accumulation: a pathway for NAFL to NASH transition
2020 · Genta Kakiyama, Dalila Marques, et al. · Journal of Lipid Research · 62
PDF
Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
2016 · Kenji Suzuki, Somasundaram Arumugam, et al. · PLoS ONE · 50
PDF
Characterization of non-alcoholic steatohepatitis-derived hepatocellular carcinoma as a human stratification model in mice.
2014 · Kazuki Takakura, Shigeo Koido, et al. · PubMed · 36
Anti‐fibrotic activity of Euglena gracilis and paramylon in a mouse model of non‐alcoholic steatohepatitis
2018 · Ayaka Nakashima, Ryota Sugimoto, et al. · Food Science & Nutrition · 33
Aberrant glycosaminoglycan biosynthesis by tumor suppressor EXTL2 deficiency promotes liver inflammation and tumorigenesis through Toll‐like 4 receptor signaling
2020 · Satomi Nadanaka, Taishi Hashiguchi, et al. · The FASEB Journal · 29
PDF
Involvement of Human Natural Killer-1 (HNK-1) Sulfotransferase in the Biosynthesis of the GlcUA(3-O-sulfate)-Gal-Gal-Xyl Tetrasaccharide Found in α-Thrombomodulin from Human Urine
2011 · Taishi Hashiguchi, Shuji Mizumoto, et al. · Journal of Biological Chemistry · 29
PDF
Inhibition of Cell Proliferation and Growth of Pancreatic Cancer by Silencing of Carbohydrate Sulfotransferase 15 In Vitro and in a Xenograft Model
2015 · Kazuki Takakura, Yuichiro Shibazaki, et al. · PLoS ONE · 28
PDF
Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH
2018 · Daniela Carmen Oniciu, Taishi Hashiguchi, et al. · PLoS ONE · 27
PDF
Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis
2018 · Suliman Al-Fayoumi, Taishi Hashiguchi, et al. · Journal of Experimental Pharmacology · 27
PDF
Demonstration of the hepatocyte growth factor signaling pathway in the in vitro neuritogenic activity of chondroitin sulfate from ray fish cartilage
2011 · Taishi Hashiguchi, Takanari Kobayashi, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 25
PDF
Analysis of the structure and neuritogenic activity of chondroitin sulfate/dermatan sulfate hybrid chains from porcine fetal membranes
2009 · Taishi Hashiguchi, Shuji Mizumoto, et al. · Glycoconjugate Journal · 15
PDF
Co-occurrence of non-alcoholic steatohepatitis exacerbates psoriasis associated with decreased adiponectin expression in a murine model
2023 · Daiki Takezaki, Shin Morizane, et al. · Frontiers in Immunology · 14
PDF
850f Anti-NASH Effects of Solithromycin in NASH-HCC Mouse Model
2014 · Prabhavathi Fernandes, Taishi Hashiguchi, et al. · Gastroenterology · 11
PDF
StarD5 levels of expression correlate with onset and progression of steatosis and liver fibrosis
2024 · Genta Kakiyama, Kei Minoiwa, et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 9
Abstract 3748: Clinicopathological characterization of non-alcoholic Steatohepatitis (NASH)-derived hepatocellular carcinoma (HCC) as a patient stratification model in mice
2014 · Kazuki Takakura, Masato Fujii, et al. · Cancer Research · 3
Sa1669 Inhibition of the Ileal Bile Acid Transporter (IBAT) by A4250 Reduces Hepatic Damage in a Mouse Model of Non-Alcoholic Steatohepatitis (NASH)
2016 · Per-Göran Gillberg, Erik Lindstrom, et al. · Gastroenterology · 1
Su1958 A Novel Murine Model Recapitulates the Pathogenesis of Human Non-Alcoholic Steatohepatitis (NASH) and NASH-Related Hepatocellular Carcinoma
2012 · Masato Fujii, Yuichiro Shibazaki, et al. · Gastroenterology · 1
WCN26-6275 Single-Agent Treatment with an ALK5 Inhibitor or an SGLT2 Inhibitor (Dapagliflozin) Attenuates Renal Fibrosis in the UUO Mouse Model
2026 · Taishi Hashiguchi · Kidney International Reports
PDF
Leronlimab A Humanized Anti-CCR5 Monoclonal Antibody Ameliorates Hepatic Fibrosis in Two Preclinical Fibrosis Mouse Models
2026 · Melissa Palmer, Taishi Hashiguchi, et al. · ASEAN Journal of Psychiatry
PDF
1502-P: Metabolic Dysfunction Associated Steatohepatitis–Derived HCC Model Mouse for Cancer Immunology
2024 · TAISHI HASHIGUCHI · Diabetes
FRI-531 Metabolic dysfunction associated steatohepatitis derived HCC model mouse for immune-oncology
2024 · Taishi Hashiguchi · Journal of Hepatology
Pegozafermin inhibits NASH-induced hepatocellular carcinoma in the STAM™ mouse model
2023 · Maya Margalit, Moti Rosenstock, et al. · Journal of Hepatology
Works count: 32
Citation count: 967
H-index: 14
I10-index: 16
Year
Topic
Type